| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2015 | A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients | Chuang, M.-K.; Chiu, Y.-C.; Chou, W.-C.; Hou, H.-A.; Chuang, E.Y.; Tien, H.-F.; ERIC YAO-YU CHUANG | Leukemia | 33 | 41 | |
| 2019 | Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study | Liu, J.-H.; Liao, X.-W.; Chen, C.-H.; Yao, M.; Li, C.-C.; Lin, C.-T.; Tsai, C.-H.; Chou, W.-C.; Hou, H.-A.; Huang, S.-Y.; Wu, S.-J.; Chen, Y.-C.; Tien, H.-F.; Tang, J.-L.; Ko, B.-S. | British Journal of Haematology | | 4 | |
| 2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | Ko, B.-S.; Wang, Y.-F.; Li, J.-L.; Li, C.-C.; Weng, P.-F.; Hsu, S.-C.; Hou, H.-A.; Huang, H.-H.; Yao, M.; Lin, C.-T.; Liu, J.-H.; Tsai, C.-H.; Huang, T.-C.; Wu, S.-J.; Huang, S.-Y.; Chou, W.-C.; Tien, H.-F.; Lee, C.-C.; Tang, J.-L. | EBioMedicine | | 0 | |
| 2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | Ko, B.-S.; Wang, Y.-F.; Li, J.-L.; Li, C.-C.; Weng, P.-F.; Hsu, S.-C.; Hou, H.-A.; Huang, H.-H.; Yao, M.; Lin, C.-T.; Liu, J.-H.; Tsai, C.-H.; Huang, T.-C.; Wu, S.-J.; Huang, S.-Y.; Chou, W.-C.; Tien, H.-F.; Lee, C.-C.; Tang, J.-L. | EBioMedicine | | 26 | |
| 2016 | Genetic alterations and their clinical implications in older patients with acute myeloid leukemia | Tsai, C.-H.; Hou, H.-A.; Tang, J.-L.; Liu, C.-Y.; Lin, C.-C.; Chou, W.-C.; Tseng, M.-H.; Chiang, Y.-C.; Kuo, Y.-Y.; Liu, M.-C.; Liu, C.-W.; Lin, L.-I.; Tsay, W.; Yao, M.; Li, C.-C.; Huang, S.-Y.; Ko, B.-S.; Hsu, S.-C.; Chen, C.-Y.; Lin, C.-T.; Wu, S.-J.; Tien, H.-F.; CHI-TE LIU | Leukemia | 56 | 75 | |
| 2016 | Genetic alterations and their clinical implications in older patients with acute myeloid leukemia | Tsai, C.-H.; Hou, H.-A.; Tang, J.-L.; Liu, C.-Y.; Lin, C.-C.; Chou, W.-C.; Tseng, M.-H.; Chiang, Y.-C.; Kuo, Y.-Y.; Liu, M.-C.; Liu, C.-W.; Lin, L.-I.; Tsay, W.; Yao, M.; Li, C.-C.; Huang, S.-Y.; Ko, B.-S.; Hsu, S.-C.; Chen, C.-Y.; Lin, C.-T.; Wu, S.-J.; Tien, H.-F. | Leukemia | | 0 | |
| 2019 | Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients | Tsai, C.-H.; Yao, C.-Y.; Tien, F.-M.; Tang, J.-L.; Kuo, Y.-Y.; Chiu, Y.-C.; Lin, C.-C.; Tseng, M.-H.; Peng, Y.-L.; Liu, M.-C.; Liu, C.-W.; Yao, M.; Lin, L.-I.; Chou, W.-C.; Chen, C.-Y.; Hou, H.-A.; Tien, H.-F. | EBioMedicine | | 13 | |
| 2017 | Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia | Tsai, C.-H.; Hou, H.-A.; Tang, J.-L.; Kuo, Y.-Y.; Chiu, Y.-C.; Lin, C.-C.; Liu, C.-Y.; Tseng, M.-H.; Lin, T.-Y.; Liu, M.-C.; Liu, C.-W.; Lin, L.-I.; Yao, M.; Li, C.-C.; Huang, S.-Y.; Ko, B.-S.; Hsu, S.-C.; Lin, C.-T.; Wu, S.-J.; Chen, C.-Y.; Tsay, W.; Chuang, E.Y.; Chou, W.-C.; Tien, H.-F.; ERIC YAO-YU CHUANG | Blood Cancer Journal | 13 | 26 | |
| 2018 | The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome | Yang, Y.-T.; Chiu, Y.-C.; Kao, C.-J.; Hou, H.-A.; Lin, C.-C.; Tsai, C.-H.; Tseng, M.-H.; Chou, W.-C.; Tien, H.-F. | Blood Cancer Journal | | 14 | |
| 2015 | TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution | Hou, H.-A.; Chou, W.-C.; Kuo, Y.-Y.; Liu, C.-Y.; Lin, L.-I.; Tseng, M.-H.; Chiang, Y.-C.; Liu, M.-C.; Liu, C.-W.; Tang, J.-L.; Yao, M.; Li, C.-C.; Huang, S.-Y.; Ko, B.-S.; Hsu, S.-C.; Chen, C.-Y.; Lin, C.-T.; Wu, S.-J.; Tsay, W.; Chen, Y.-C.; Tien, H.-F.; CHI-TE LIU | Blood Cancer Journal | 67 | 85 | |
